Synteract Centers of Therapeutic Development

Article

Applied Clinical Trials

Synteract, a full-service, Phase I-IV CRO announced the creation of therapeutic centers of development that include oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease.

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.